Characterization of steroid-binding sites by affinity labeling. Further studies of the interaction between 4-mercuri-17.beta.-estradiol and specific estrogen-binding proteins in the rat uterus

Biochemistry ◽  
1971 ◽  
Vol 10 (20) ◽  
pp. 3780-3784 ◽  
Author(s):  
Thomas G. Muldoon
1969 ◽  
Vol 244 (20) ◽  
pp. 5430-5435 ◽  
Author(s):  
Thomas G. Muldoon ◽  
James C. Warren

1971 ◽  
Vol 246 (11) ◽  
pp. 3646-3652 ◽  
Author(s):  
Manik Ganguly ◽  
James C. Warren

1983 ◽  
Vol 19 ◽  
pp. 136
Author(s):  
H.J. Grill ◽  
A. Knichel ◽  
G. Schweikhart ◽  
T. Beck ◽  
B. Manz ◽  
...  

1988 ◽  
Vol 34 (10) ◽  
pp. 2053-2057 ◽  
Author(s):  
S Raam ◽  
D M Vrabel

Abstract We present evidence to show that monoclonal antibodies to estrogen receptors (ER) in solid phase recognize the secondary estrogen binding sites with moderate to low affinity for estradiol (E2). An excellent quantitative agreement was found in five cytosols between the ER values obtained by the enzyme immunoassay (ER-EIA) and the amount of secondary estrogen binding sites measured by the assay involving dextran-coated charcoal (Clin Chem 1986;32:1496). The immunoreactive protein recognized by the antibody-coated beads, when allowed to react with ER(+) cytosols, is shown to bind [3H]estradiol only when the ligand concentration exceeds 8 nmol/L. Further biochemical and functional characterization of the immunoreactive protein is required to establish similarities/dissimilarities between this protein, high-affinity Type I ER sites, and the secondary sites such as Type II sites.


1988 ◽  
Vol 3 (3) ◽  
pp. 197-202 ◽  
Author(s):  
P. Lampertico ◽  
F. Stagni ◽  
P. Crosignani

Frozen tumor sections and/or cytological smears and aspirates from 614 pateints were studied utilizing the fluorescent estrogen binding technique of Lee. Survival analyses of the results indicated that women less than 55 years of age and with positive tumors had a statistically better disease-free interval and survived significantly longer than older patients. The method is thus an independent predictor of survival and disease-free interval in this siubgroup of breast cancer patients.


Steroids ◽  
1974 ◽  
Vol 24 (4) ◽  
pp. 437-449 ◽  
Author(s):  
Georges Michel ◽  
Ingrid Jung ◽  
Etienne-Emile Baulieu ◽  
Claude Aussel ◽  
José Uriel

Sign in / Sign up

Export Citation Format

Share Document